SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-044618
Filing Date
2023-04-12
Accepted
2023-04-12 16:33:35
Documents
1
Group Members
5AM CO-INVESTORS IV, L.P.5AM OPPORTUNITIES I (GP), LLC5AM OPPORTUNITIES I, L.P.5AM PARTNERS IV, LLCANDREW J. SCHWABDR. JOHN D. DIEKMANDR. SCOTT M. ROCKLAGE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2312518d1_sc13da.htm SC 13D/A 146394
  Complete submission text file 0001104659-23-044618.txt   148257
Mailing Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107 (415) 993-8565
5AM Ventures IV, L.P. (Filed by) CIK: 0001589315 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109
Business Address 200 STATE STREET 13TH FLOOR BOSTON MA 02109 6469322774
Pear Therapeutics, Inc. (Subject) CIK: 0001835567 (see all company filings)

IRS No.: 854103092 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92635 | Film No.: 23816074
SIC: 8000 Services-Health Services
Industrial Applications and Services